KORU Medical Systems, Inc. (NASDAQ: KRMD) is a Healthcare company (Medical - Instruments & Supplies) with a market capitalization of $151M. The Maz Rating grades it against the other companies in its sector.
KORU Medical Systems, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $3.49, KORU Medical Systems, Inc. trades at 3.2x sales and 0.0x book value. Over the last twelve months it generated about $47M of revenue and a net loss of $774398. It runs a gross margin of 63.2%, an operating margin of -1.3% and a net margin of -1.8%. It shows return on equity of -0.0%, return on invested capital of -0.0% and a free cash flow yield of -0.6%. On the balance sheet: a debt-to-equity ratio of 0.16 and a current ratio of 2.97. Over the past 52 weeks the share price ranged from $2.86 to $6.61, with a beta of 0.39.
KORU Medical Systems, Inc. does not currently pay a dividend.
5 Wall Street analyst ratings cover the stock: 4 Buy and 1 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
KORU Medical Systems, Inc. is dedicated to the development, manufacturing, and commercialization of mobile medical devices, primarily serving the ambulatory infusion market across both the United States and international territories. The company's primary offerings revolve around mechanical infusion solutions, notably their FREEDOM infusion systems. These comprehensive systems encompass components such as the FREEDOM60 and FreedomEdge syringe drivers, alongside specialized HIgH-Flo subcutaneous safety needle sets and precision flow rate tubing. Beyond their product range, KORU Medical also supplies educational content and training materials to healthcare professionals, patients, and patient advocates. The distribution of their products is managed through a combination of direct sales efforts, partnerships with medical device distributors, and online channels. Established in 1980, the firm's corporate headquarters are situated in Chester, New York.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
It depends on the standard you follow. As of September 2026, KORU Medical Systems, Inc. (KRMD) passes 2 of 5 published Shariah screening standards checked by Maz Vantage: it passes MSCI and FTSE, and fails AAOIFI, S&P Global and Dow Jones.
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 2154796.1% / 30% · (Cash+Inv) / Mkt Cap (36m) 5010955.9% / 30% · Interest income / Revenue 0.53% / 5% | Fail |
| S&P Global | Debt / Mkt Cap (36m) 2154796.1% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 5010955.9% / 33% · Receivables / Mkt Cap (36m) 4.75% / 49% · Interest income / Revenue 0.53% / 5% | Fail |
| Dow Jones | Debt / Mkt Cap (24m) 2154796.1% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 5010955.9% / 33.33% · Receivables / Mkt Cap (24m) 4.75% / 33.33% · Interest income / Revenue 0.53% / 5% | Fail |
| MSCI | Debt / Avg Assets (4Q) 11.0% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 25.6% / 33.33% · Receivables / Avg Assets (4Q) 0.00% / 33.33% · Interest income / Revenue 0.53% / 5% | Pass |
| FTSE | Debt / Total Assets 11.0% / 33.33% · (Cash+ST Inv) / Total Assets 25.6% / 33.33% · (Cash+Recv) / Total Assets 25.6% / 33.33% · Interest income / Revenue 0.53% / 5% | Pass |
It depends on the standard you follow. As of September 2026, KORU Medical Systems, Inc. (KRMD) passes 2 of 5 published Shariah screening standards checked by Maz Vantage: it passes MSCI and FTSE, and fails AAOIFI, S&P Global and Dow Jones.
No. KORU Medical Systems, Inc. is over the AAOIFI limit on Debt / Mkt Cap (36m) and (Cash+Inv) / Mkt Cap (36m).
About 0.53% of each dividend: KORU Medical Systems, Inc.'s interest income as a share of its revenue. Give that share to charity; the dividend purification calculator works it out per holding.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.